Learn and earn CE credits online with dvm360 Flex
Sponsored by Elanco. Head to dvm360 Flex and login or create a free CE account and claim your credit after listening to this episode.
Canine Parvovirus (CPV) infection is one of the most common and serious infectious diseases of puppies and dogs younger than 6 months of age. We will discuss the diagnosis and differential diagnosis of CPV and emphasize expected laboratory changes including hematologic and electrolyte abnormalities.
Exciting new treatments for CPV will be discussed including the Canine Parvovirus Monoclonal Antibody (CPMA) which is the first and only USDA-conditionally approved monoclonal antibody treatment that targets CPV. CPMA selectively binds and blocks canine parvovirus from entering and destroying the enterocytes stopping this destructive and potentially deadly virus.